NFKB1 and Alzheimer disease: Early reports have shown that TNF-α levels are elevated in the cerebrospinal fluid of AD patients compared to cognitive normal controls, and high levels of TNF-α activate the NF-κB inflammatory signaling pathways, further exacerbating the pathological features of Aβ deposition and tau hyperphosphorylation.